The national drug regulator conducted inspections after cough syrup made in the country was linked to deaths of children India’s drug regulator has carried out inspections at hundreds of pharmaceutical plants after cough syrup produced in the country and exported worldwide was linked to the deaths of dozens of children. The Central Drugs Standard Control Organization (CDSCO) has conducted “risk-based inspections” at more than 400 pharmaceutical manufacturing units over the past year and a half, agency chief Rajeev Raghuvanshi revealed at an industry event on Thursday. Some 36% of these were closed down, he added
Hence then, the article about more than 100 pharma plants shut in india amid quality crackdown was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( More than 100 pharma plants shut in India amid quality crackdown )